Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Scientists suggest vibrational spectroscopy and nuclear magnetic resonance to evaluate drug concentrations

Scientists at Baltic Federal University have suggested evaluating concentration and chemical composition of drugs by means of vibrational spectroscopy and nuclear magnetic resonance instead of conventional complex approaches.

20 Dec 2022

Decoding nucleic acid-based drugs and vaccines through SEC-SLS analysis

In this interview, Malvern Panalytical’s Product Technical Specialist, Stefan Cairns, discusses how SEC-SLS can be used to understand MRNA vector composition by referencing his latest publication.

From Malvern Panalytical 19 Dec 2022

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

Florida International University researchers have moved a step closer to producing synthetic arsenic-based drugs in their quest to solve an urgent worldwide health problem -the growing number of infections that have become antibiotic-resistant.

16 Dec 2022

Global Access Diagnostics joins consortium to co-develop on-farm rapid test for calf pneumonia, RaDiCal

Global Access Diagnostics (GADx) today announced the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, one of the most significant diseases affecting calves

From Global Access Diagnostics 16 Dec 2022

mRNA vaccine methodologies: Production, value and spectrometer use

To be decided by the editor

From Thermo Fisher Scientific – Materials & Structural Analysis 16 Dec 2022

Incidence of Parkinson's disease among older adults is 50% higher than current estimates, study reveals

A new study reveals that the annual incidence of Parkinson's disease (PD) among older adults is 50% higher than current estimates of 60,000 diagnoses annually.

15 Dec 2022

New project on ultrasound device for treatment of neuropathic pain to receive NIH funding

Researchers from Florida Atlantic University's Schmidt College of Medicine, in collaboration with Albany Medical College in New York, are among seven institutions nationwide selected to receive funding from the National Institutes of Health for their innovative pilot projects to enable new medical devices to diagnose and treat both acute and chronic disorders from neuropathic pain to mental illness.

15 Dec 2022

What Germany’s coal miners can teach America about medical debt

Almost every day, Dr. Eckart Rolshoven sees the long shadow of coal mining in his clinic near the big brownstone church that dominates this small town in Germany's Saarland.

14 Dec 2022

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

A patient with relapsed T cell leukemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

12 Dec 2022

In rural America, deadly costs of opioids outweigh the dollars tagged to address them

Tim Buck knows by heart how many people died from drug overdoses in his North Carolina county last year: 10. The year before it was 12 — an all-time high.

12 Dec 2022

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology Annual Meeting.

12 Dec 2022

UKSRC researchers work with community partners to protect Kentuckians from 'forever chemicals'

Nearly every person in the United States has been exposed to per- and polyfluorinated alky substances (PFAS) at some point in their life.

7 Dec 2022

Scientists report the in vitro production of infectious Plasmodium falciparum sporozoites

Scientists from Sanaria Inc., and collaborators at multiple institutions publish results in Nature reporting "In vitro production of infectious Plasmodium falciparum sporozoites."

7 Dec 2022

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

7 Dec 2022

Shenandoah Biotechnology introduces expanded range of CTGrade recombinant proteins manufactured following cGMP practices

Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific company and leading manufacturer of recombinant proteins, today announced it has expanded its CTGrade portfolio of cytokines and growth factors for cell and gene therapies manufactured following cGMP guidelines.

From FUJIFILM Irvine Scientific 7 Dec 2022

The critical role of flow cytometry in CAR+ T-Cell trials

In this interview, Ryan Muise talks to AZoNetwork about the added value of using flow cytometry in CAR T-Cell clinical trials.

From Cerba Research 6 Dec 2022

Pre-Plated Assay Solutions That Can Help Accelerate Biotech

In this interview, we speak with University of Warwick spin-out Cryologyx about their innovative new technology that hopes to revolutionize cell-based assays for researchers across life sciences and drug discovery.

From Cryologyx Ltd 6 Dec 2022

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Researchers from the United States developed an affordable, non-invasive, inhalable prophylactic treatment consisting of immunoglobulin (Ig) A fused nanobodies against the SARS-CoV-2 Omicron variant.

2 Dec 2022

Scaling up the production of customized immune cells for drug development and testing

To prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells.

1 Dec 2022

£12 million awarded to innovative UK regulators to help drive technology and personalized medicine

Science Minister George Freeman has today (30 November) awarded up to £12 million to UK regulators to help drive forward innovation, remove red tape and establish the UK as world leader in technologies of the future - from AI to help treat rare diseases, to drones monitoring safety on construction sites.

30 Nov 2022

Manufacturing News and Research

Further Reading

Scientists suggest vibrational spectroscopy and nuclear magnetic resonance to evaluate drug concentrations

Decoding nucleic acid-based drugs and vaccines through SEC-SLS analysis

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

Global Access Diagnostics joins consortium to co-develop on-farm rapid test for calf pneumonia, RaDiCal

mRNA vaccine methodologies: Production, value and spectrometer use

Incidence of Parkinson's disease among older adults is 50% higher than current estimates, study reveals

New project on ultrasound device for treatment of neuropathic pain to receive NIH funding

What Germany’s coal miners can teach America about medical debt

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

In rural America, deadly costs of opioids outweigh the dollars tagged to address them

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

UKSRC researchers work with community partners to protect Kentuckians from 'forever chemicals'

Scientists report the in vitro production of infectious Plasmodium falciparum sporozoites

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Shenandoah Biotechnology introduces expanded range of CTGrade recombinant proteins manufactured following cGMP practices

The critical role of flow cytometry in CAR+ T-Cell trials

Pre-Plated Assay Solutions That Can Help Accelerate Biotech

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Scaling up the production of customized immune cells for drug development and testing

£12 million awarded to innovative UK regulators to help drive technology and personalized medicine

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News